2-METHYL-2-(4-OXETAN-3-YL-PIPERAZIN-1-YL)-PROPIONALDEHYDE, 95.0%, 5g

3,4-Dihydro-2H-benzo[1,4]oxazine-2-carboxylic acidethyl ester hydrochloride, 95.0%, 10g

4-(2,2,2-Trifluoroacetamido)butanoic acid, 95.0%, 5g

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,32 mm, 0,10 µm, 1 pièce(s)

5'-Chloro-2'-hydroxyacetophenone, 99.0%, 25g

3-BROMO-4-FLUORO-1H-INDAZOLE, 95%, 5g

4-Bromo-2,6-diisopropylaniline>98.0%(T)5g

(2-Aminopyridin-3-yl)boronic acid, 98+%, 250mg

2-Nitrobenzhydrazide, 95.0%, 1g

3-amino-4-hydroxypent-4-en-2-one hydrochloride, 95%, 5g

(1S,2R)-1-Phenyl-2-(1-pyrrolidinyl)propan-1-ol>97.0%(GC)5g

4-[(4-Aminopiperidin-1-yl)methyl]benzonitrile dihydrochloride, 95.0%, 1g

4-Chloro-1H-pyrazolo[4,3-c]pyridine, 95.0%, 5g